Ventyx Historical Balance Sheet
| VTYX Stock | USD 2.65 0.11 4.33% |
Trend analysis of Ventyx Biosciences balance sheet accounts such as Total Assets of 207.1 M, Short Long Term Debt Total of 8.4 M, Other Current Liabilities of 16.3 M or Total Current Liabilities of 11.6 M provides information on Ventyx Biosciences' total assets, liabilities, and equity, which is the actual value of Ventyx Biosciences to its prevalent stockholders. By breaking down trends over time using Ventyx Biosciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Ventyx Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ventyx Biosciences is a good buy for the upcoming year.
Ventyx |
About Ventyx Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Ventyx Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Ventyx Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ventyx Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ventyx currently owns. An asset can also be divided into two categories, current and non-current.
Ventyx Biosciences Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Ventyx Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Ventyx Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Ventyx Biosciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Ventyx Biosciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most accounts from Ventyx Biosciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Ventyx Biosciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ventyx Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Ventyx Stock please use our How to Invest in Ventyx Biosciences guide.At this time, Ventyx Biosciences' Other Current Liabilities is fairly stable compared to the past year. Total Stockholder Equity is likely to rise to about 256.1 M in 2024, whereas Total Assets are likely to drop slightly above 207.1 M in 2024.
| 2021 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 1.6M | 12.5M | 8.4M | Total Assets | 291.5M | 277.7M | 207.1M |
Ventyx Biosciences balance sheet Correlations
Click cells to compare fundamentals
Ventyx Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Ventyx Stock Analysis
When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.